NCT06832969尚未招募不适用
A Clinical Study on Verifying the Cryoablation Technique for Peripheral Lung Malignancies Under Bronchoscopy Guidance
Guangzhou Medical University0 个研究点目标入组 10 人开始时间: 2025年2月15日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
- 主要终点
- Complete Ablation Rate
研究概览
简要总结
To assess the safety and effectiveness of bronchoscopy-guided cryoablation with cold verification for peripheral lung malignancies.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •(1) Age ≥ 18 years, with no gender restrictions; (2) Diagnosed as having peripheral lung cancer, with the maximum diameter of the tumor being ≤ 3 cm and the number of tumors being ≤ 3; (3) The lesion intended for ablation is evaluated as feasible for bronchoscopy-guided cryoablation therapy; (4) The subject refuses or is deemed unsuitable for radiotherapy/chemotherapy, or has no response to previous radiotherapy/chemotherapy, or has disease progression after radiotherapy/chemotherapy; (5) Assessed as ineligible for surgery or refuses surgery and radiotherapy, consents to receive initial ablation treatment and signs the informed consent form.
排除标准
- •(1) Diffuse lesions in both lungs where ablation therapy fails to improve the condition; (2) Examinations within one month prior to the operation reveal the presence of hilar lymph node metastasis or extrapulmonary metastasis (except for cases where extrapulmonary metastasis has been controlled through local treatment); (3) Existence of contraindications for bronchoscopy, or inability of the patient to tolerate or cooperate with bronchoscopy; (4) Severe bleeding tendencies or uncorrectable coagulation dysfunctions (prothrombin time > 18 seconds, prothrombin activity < 40%); (5) Platelet count < 70×109/L, or discontinuation of anticoagulant and/or antiplatelet drugs less than one week before ablation (except for the prophylactic use of low-molecular-weight heparin before the operation); (6) Severe impairment of lung function with a maximum ventilation volume < 40%; (7) Concurrent presence of other tumors with extensive metastasis and an expected survival period of less than 3 months; (8) Poor overall condition (multiple metastases throughout the body, severe infection, high fever), infectious and radiation-induced inflammation around the lesion, obvious cachexia, severe dysfunction of important organs, severe anemia and short-term uncorrectable nutritional and metabolic disorders; (9) Eastern Cooperative Oncology Group (ECOG) performance status score > 2; (10) The lesion to be ablated has received radiotherapy within the past 6 months; (11) Active hepatitis B, active hepatitis C, human immunodeficiency virus (HIV) infection history (known positive for HIV1/2 antibodies), or other active infections that are judged by the researcher to potentially affect the patient's treatment; (12) Accompanied by epilepsy, history of mental illness or cognitive impairment; (13) Pregnant or lactating women, as well as male or female patients who plan to have children or become pregnant during the trial; (14) Participation in any other clinical trials within 3 months before signing the informed consent (excluding non-interventional studies); (15) Other circumstances deemed by the researcher as inappropriate for participation in this clinical trial.
结局指标
主要结局
Complete Ablation Rate
时间窗: 6 months after biopsy
It refers to the proportion of subjects in whom the major lesion remained completely ablated six months after the entire ablation procedure, as a percentage of all evaluable subjects who underwent cryoablation.
次要结局
未报告次要终点
研究者
Li Shiyue
Professor
Guangzhou Medical University
相似试验
尚未招募
不适用
Safety and feasibility of the use of cryoablation in patients with brain neoplasmbrain neoplasmbrain tumors1002765610019190NL-OMON53649Erasmus MC, Universitair Medisch Centrum Rotterdam30
招募中
Unknown
Effect of cryotherapy (cryoablation) of posterior nasal nerve on rhinitisAllergic or non-allergic rhinitis or a combination of both.Vasomotor and allergic rhinitisIRCT20220421054606N1Bagheiat-allah University of Medical Sciences40
已完成
不适用
Evaluation of Balloon-based Cryoablation of Human Esophageal Epitheliumesophageal neoplasm100179901001799110017998esophageal cancerNL-OMON36325C2 Therapeutics, Inc.15
已完成
不适用
Coldplay Cryoablation of Dysplastic Squamous Tissue in Patients With Esophageal Squamous Cell DysplasiaEsophageal Squamous Cell DysplasiaNCT02605759Pentax Medical80
已完成
不适用
Clinical Study to Evaluate CryoBalloon™ Ablation System in Patients Undergoing EsophagectomyEsophageal CancerNCT02729727Pentax Medical3